23rd May, 2011 - Dublin, Ireland

Cellix are pleased to announce the signing of an OEM manufacture and supply agreement with Cell Biolabs on a range of microfluidic biochips and accessories for cell-based assays.  Cell-Biolabs, based in San Diego, CA, will supply the biochips from their current Cell-Based Assay product range thereby diversifying their product portfolio and entering into the microfluidics field. 

Cellix is now supplying a range of biochips and accessories via an OEM supply agreement to Cell Biolabs.  The microfluidic biochips will be streamlined in Cell Biolabs’ Cell-Based Assay portfolio and may be used for a wide range of applications including investigation of platelet biology, thrombi formation, the leukocyte adhesion cascade; biofilm formation and colonisation; and oncology studies.  These biochips are compatible with standard syringe pumps from Harvard Apparatus, World Precision Instruments, KD Scientific and many more.   

Vivienne Williams, CEO, Cellix commented on the deal: “This is an exciting development for Cellix.  Cell Biolabs has great expertise in developing products for the cell-based assay field.  They know and understand this market and having clearly recognised the benefits of microfluidics technology; such as reduced reagent and sample volumes, they can now incorporate this technology into their assay portfolio for the benefit of their customers.”

Ken Rosser, Director of Business Development at Cell Biolabs, San Diego, CA, USA; says “The Cellix biochips are a perfect fit for our Cell-Based Assay product portfolio. This technology will help us continue to achieve our goal of advancing cell biology research with innovative tools that facilitate discovery of the mechanisms underlying cell function and disease”.

To find out more about Cellix’s biochips available from Cell Biolabs, visit www.cellbiolabs.com

About Cellix:

Cellix is an Irish based company producing a range of precise microfluidic pumping solutions and disposable biochips for cell-based assays in applied biological research and drug screening.  Cellix's VenaFlux Platform and customised platforms provide continuous blood flow (via Mirus Nanopump) and simulate blood vessels (via capillaries in our range of biochips) in a robust in vitro micro-environment.  Investigation of platelet biology, thrombi formation, the leukocyte adhesion cascade; biofilm formation and colonisation; and evaluation of stents and stent materials are key applications of our technology where customers cite the "reduction in blood sample required; ease of use and physiological relevance" of the assays as being of key importance.  Customers include academics, blood centers and pharmaceutical and biotechnology companies around the world.  The Company is headquartered in Dublin, and maintains an office in New York city.  For further information on Cellix's biochip range, click here.

About Cell Biolabs:

Cell Biolabs Inc. proudly develops novel assays and reagents to advance cell and molecular biology.  We are scientists driven by a devotion to discovery and innovation and we work hard every day to find new ways to streamline life science research.  Whether you trust us for our Cell-Based Assays, Viral Expression Systems, Oxidative Stress Assays or reagents for Cell Signalling, Stem Cell Research or miRNA analysis, we can help you with experimental design, assay protocols and data analysis.  For more information on our new biochip product range for Cell-Based Assays, please contact us:  Tel: 1-858-271-6500 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it . 

For more information, please contact Cellix: 

Tel:  +353-1-896-2799

Email:     This e-mail address is being protected from spambots. You need JavaScript enabled to view it